Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex

被引:36
作者
Gerits, Annelies [1 ]
Vancraeyenest, Pascaline [1 ]
Vreysen, Samme [2 ]
Laramee, Marie-Eve [2 ]
Michiels, Annelies [3 ,4 ]
Gijsbers, Rik [4 ,5 ]
Van den Haute, Chris [3 ,4 ]
Moons, Lieve [6 ]
Debyser, Zeger [5 ]
Baekelandt, Veerle [3 ]
Arckens, Lutgarde [2 ]
Vanduffel, Wim [1 ,7 ,8 ]
机构
[1] Katholieke Univ Leuven, Lab Neuro & Psychophysiol, Dept Neurosci, O&N2 Herestr 49 Bus 10-21, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, Fac Sci, B-3000 Leuven, Belgium
[3] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, B-3000 Leuven, Belgium
[4] Katholieke Univ Leuven, Leuven Viral Vector Core, B-3000 Leuven, Belgium
[5] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Dept Neurosci, B-3000 Flanders, Belgium
[6] Katholieke Univ Leuven, Lab Neural Circuit Dev & Regenerat, Fac Sci, B-3000 Leuven, Belgium
[7] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[8] Harvard Univ, Sch Med, Dept Radiol, Charlestown, MA 02129 USA
关键词
promoters; histology; monkey; optogenetics; gene transfer; cell-specific expression; CENTRAL-NERVOUS-SYSTEM; NONHUMAN PRIMATE BRAIN; VIRUS AAV; LENTIVIRAL VECTORS; GENE-EXPRESSION; PROTEIN-KINASE; IN-VIVO; NEUROLOGICAL DISORDERS; TRANSGENE EXPRESSION; PARKINSONS-DISEASE;
D O I
10.1117/1.NPh.2.3.031209
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Viral vector-mediated expression of genes (e. g., coding for opsins and designer receptors) has grown increasingly popular. Cell-type specific expression is achieved by altering viral vector tropism through cross-packaging or by cell-specific promoters driving gene expression. Detailed information about transduction properties of most recombinant adeno-associated viral vector (rAAV) serotypes in macaque cortex is gradually becoming available. Here, we compare transduction efficiencies and expression patterns of reporter genes in two macaque neocortical areas employing different rAAV serotypes and promoters. A short version of the calmodulin-kinase-II (CaMKIIa0.4) promoter resulted in reporter gene expression in cortical neurons for all tested rAAVs, albeit with different efficiencies for spread: rAAV2/5>>rAAV2/7>rAAV2/8>rAAV2/9>>rAAV2/1 and proportion of transduced cells: rAAV2/1>rAAV2/5>rAAV2/7= rAAV2/9>rAAV2/8. In contrast to rodent studies, the cytomegalovirus (CMV) promoter appeared least efficient in macaque cortex. The human synapsin-1 promoter preceded by the CMV enhancer (enhSyn1) produced homogeneous reporter gene expression across all layers, while two variants of the CaMKIIa promoter resulted in different laminar transduction patterns and cell specificities. Finally, differences in expression patterns were observed when the same viral vector was injected in two neocortical areas. Our results corroborate previous findings that reporter-gene expression patterns and efficiency of rAAV transduction depend on serotype, promoter, cortical layer, and area. (C) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.
引用
收藏
页数:17
相关论文
共 82 条
  • [1] Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors
    Alisky, JM
    Hughes, SM
    Sauter, SL
    Jolly, D
    Dubensky, TW
    Staber, PD
    Chiorini, JA
    Davidson, BL
    [J]. NEUROREPORT, 2000, 11 (12) : 2669 - 2673
  • [2] An optical neural interface:: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology
    Aravanis, Alexander M.
    Wang, Li-Ping
    Zhang, Feng
    Meltzer, Leslie A.
    Mogri, Murtaza Z.
    Schneider, M. Bret
    Deisseroth, Karl
    [J]. JOURNAL OF NEURAL ENGINEERING, 2007, 4 (03) : S143 - S156
  • [3] Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
    Aschauer, Dominik F.
    Kreuz, Sebastian
    Rumpel, Simon
    [J]. PLOS ONE, 2013, 8 (09):
  • [4] The AAV Vector Toolkit: Poised at the Clinical Crossroads
    Asokan, Aravind
    Schaffer, David V.
    Samulski, R. Jude
    [J]. MOLECULAR THERAPY, 2012, 20 (04) : 699 - 708
  • [5] Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
    Bankiewicz, Krystof S.
    Forsayeth, John
    Eberling, Jamie L.
    Sanchez-Pernaute, Rosario
    Pivirotto, Philip
    Bringas, John
    Herscovitch, Peter
    Carson, Richard E.
    Eckelman, William
    Reutter, Bryan
    Cunningham, Janet
    [J]. MOLECULAR THERAPY, 2006, 14 (04) : 564 - 570
  • [6] BENSON DL, 1991, J NEUROSCI, V11, P31
  • [7] Adeno-Associated Viral Vectors for Mapping, Monitoring, and Manipulating Neural Circuits
    Betley, J. Nicholas
    Sternson, Scott M.
    [J]. HUMAN GENE THERAPY, 2011, 22 (06) : 669 - 677
  • [8] The Birth of Optogenetics
    Boyden, Edward S.
    [J]. SCIENTIST, 2011, 25 (07) : 30 - 35
  • [9] Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
    Burger, C
    Gorbatyuk, OS
    Velardo, MJ
    Peden, CS
    Williams, P
    Zolotukhin, S
    Reier, PJ
    Mandel, RJ
    Muzyczka, N
    [J]. MOLECULAR THERAPY, 2004, 10 (02) : 302 - 317
  • [10] Butler James., 2012, BIOSCI HORIZ, V5, phzr020, DOI DOI 10.1093/biohorizons/hzr020